Physician profile
Ashley E Romans
NPI 1356639959
$584.36
in general payments reported to CMS, 2019-2025
14 companies · $17.26 in 2025
The $17.26 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $182 · 2023: $184 · 2024: $17.23 · 2025: $17.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.80 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $283.83 | 2021-2024 | |
| Pfizer INC. | $40.40 | 2021 | |
| Avion Pharmaceuticals | $38.53 | 2022 | |
| Millicent US INC | $26.70 | 2023 | Femring |
| Bayer Healthcare Pharmaceuticals INC. | $26.33 | 2022 | |
| Therapeuticsmd, INC. | $24.91 | 2022 | |
| Organon LLC | $24.66 | 2023 | Nexplanon |
| Sumitomo Pharma America, INC. | $19.94 | 2023 | Myfembree |
| Myovant Sciences INC. | $18.60 | 2022 | |
| Mayne Pharma Commercial LLC | $18.18 | 2023 | |
| Astellas Pharma US INC | $18.18 | 2023 | Veozah |
| Endotronix, INC. | $17.26 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Coopersurgical, INC. | $15.10 | 2021 | |
| Exeltis, USA INC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Romans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.